21
Serialisation status and implications SARQA, Höstkonferensen Mölndal, Sweden 19.11.2015 Søren Andersen

Serialisation status and implicationsSerialisation – status and implications SARQA, Höstkonferensen Mölndal, Sweden 19.11.2015 Søren Andersen

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

  • Serialisation –status and implications

    SARQA, HöstkonferensenMölndal, Sweden

    19.11.2015 Søren Andersen

  • Who are we?

    2

    • An international company

    specialised in Pharma

    engineering

    • Over 85 years of experience in

    Pharma engineering

    • Close to 2,000 professionals with

    extensive Pharma project

    experience and technical

    expertise

    • Around 3,000 projects per year

  • We are focused on Pharma engineering

    3

    • More than 85 years of Pharma and

    biotech engineering experience

    • 99 percent of our activities in this

    industry

    • GMP, pharmaceutical process and

    business conditions is our daily life

    • All of our close to 2,000 employees are

    used to working in Pharma

    • Leading experts with deep insight in

    Pharma engineering

    • Many of our engineers have been

    working in production or development

    Master planning

    Critical tasksCore operations validation

    cleanrooms

    Tech transfer

    Quality by design

    aseptic environments

    API

    Drug manufacturing

    Devices

    Project management

    Single-use technology

    filling lines

    Facility design

    Feasibility testing

    GMP Utility systems

    Basic designHigh potency

    Process equipment

  • Assisting you within the entire manufacturing lifecycle

    4

    Expert Pharma engineering and consultancy

    to support you in all phases of

    pharmaceutical production

    • Consulting on how to best meet the ever-

    changing demands in Pharma production

    • Fast-track establishment of

    pharmaceutical R&D and production

    facilities

    • Optimisation and debottlenecking of

    ongoing production to meet changing

    product, quality, capacity and efficiency

    requirements

  • Introduction - Serialisation

    • “License to Operate”

    • GDP/GSP compliance

    • RA compliance to Anti-counterfeit laws

    • Tender requirements from GPO’s

    • Brand protection

    • In short:

    • Unit Cost and Profitability are

    under threat

    • Invest is high

    5

    Profitability & Cost

    Tender requirements from GPO’s

    RA compliance to Anti-

    counterfeit laws

    GDP/GSP compliance

    Brand protection

    “Serialisation” is not just solved by

    adding another Band-Aid. It’s a long-

    term commitment and investment so

    why not reach out for World Class

    Pharmaceutical Packaging?

  • Definitions

    6

  • Definitions

    7

  • The Chain from manufacture to customer (EU)

    8

    EU Delegated Act is not

    100% clear on verification

    in the supply Chain

  • eLeaflets® are on the move in Australia and EU is working on a program

    for implementationData exchange / fact

    based information

    Looping back

    Continues management

    of data

    “Meet the Doctor”

    • Voice information

    • Interactive user guide

    • Videos

    • Adverse reaction warnings

    • “Marketing” of improved

    and new products to match

    client profile

    • Q&A sessions

    Serialisation and the opportunities

    Knowledge

    • Customer interaction

    • Real time sales figures

    • Faster responsiveness

    • Increase customer value

    9

  • Serialisation, Traceability and Tamper Verification

    10

  • Global Serialisation and Traceability

    11

  • Key Serialisation and Traceability Requirements

    12

  • Key Serialisation and Traceability Requirements

    13

  • Timetables: Europe and Turkey

    14

  • Timetables: Asia and Australia

    15

  • Timetables: Americas, Russia and Middle-East

    16

    *) Revoked by new bills

    Suspended

  • Market Specific Requirements

    17

  • Market Specific Requirements

    18

  • Key Takeaways

    19

    • Global readiness is not only about serialisation

    • Traceability

    • Tamper evidence/verification

    • Partner readiness

    • Regulatory reporting

    • Implementation orchestration: collaboration internally and with supply chain partners

    • Global requirements are very diverse and fast changing: market and regulatory intelligence is essential

    • Better to be ready early than late – so start preparation now

    • Internal decision making and commitment will take time

    • Scope is larger than you might even imagine

    • Budgets are big in comparison to the usual production projects

    • New technologies and competences required

    • Vendors are already fully booked for 8-12 months

    • Your partners may not be ready on timetable

  • NNE Pharmaplan Serialisation offerings

    20

    Cu

    sto

    me

    r

    Automation & IT• Manufacturing Information

    Systems

    • PLC/SCADA

    • System Interfaces

    Finished Products• Packaging line knowledge

    • Vendor coordination

    • Equipment specifications

    • Project Management

    Serialisation software• Configuration

    • Communications with vendor

    • Interfaces to Equipment

    • Knowledge of all major SW

    GMP Compliance• Validation documentation

    • Risk Assessment

    • Test Plans

    • SOP

    Logistic & Warehouse• Product distribution mapping

    • Product flow

    • Contract packaging mapping

    Management Consulting• Change Management

    • Training

    • OEE

    • Performance optimization

  • 21